Global Innovation Policy Center
GIPC is leading efforts to promote innovation and creativity globally by advocating for strong IP standards.
![](https://uschamber.imgix.net/https%3A%2F%2Fwww.uschamber.com%2Fassets%2Fimages%2FGIPC-GettyImages-1327977763.jpg?auto=compress%2Cformat&fit=clip&fm=jpg&q=10&w=100&s=97070c91fe13de4c4699812a7563cacc)
The U.S. Chamber of Commerce’s Global Innovation Policy Center is working around the world to champion innovation and creativity through intellectual property standards that create jobs, save lives, advance global economic and cultural prosperity, and generate breakthrough solutions to global challenges.
Explore more
Leadership
David HirschmannExecutive Vice President, New Strategic Initiatives Tom QuaadmanExecutive Vice President, Center for Capital Markets Competitiveness (CCMC) Brad WattsVice President, Patents and Innovation Policy, Global Innovation Policy Center (GIPC), U.S. Chamber of Commerce Kelly AndersonExecutive Director, International Policy
Latest Content
This Statement for the Record was sent to the Members of the House Committee on Energy and Commerce, for the hearing, “Lowering Unaffordable Costs: Legislative Solutions to Increase Transparency and Competition in Health Care.”
When we recognize and address challenges that women innovators, creators, and entrepreneurs face and when we foster more inclusion and creativity, all of society benefits.
Urge your member of Congress to protect American patients and stop this price control regime.
Amazon's third annual Brand Protection Report highlights the company's investment in preventing the sale of counterfeit products on its platform and ensuring safe and authentic goods for customers.
This Hill letter was sent to Members of the Senate Committee on Health, Education, Labor, and Pensions on its hearing entitled “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?”
The U.S. Chamber of Commerce's ‘Patient Access Report’ reveals how government price controls endanger patients' access to groundbreaking medicines.
According to a new U.S. Chamber study, access to medical innovation thrives in countries with smart public policies and free market competition.